ArticleIn vivo (Athens, Greece)
Prognostic Superiority of the White Cell-to-Lymphocyte Ratio (WLR) in Predicting Overall Survival in Patients With Gliomas.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ERP44 Is Associated With Poor Prognosis and Promotes Proliferation and Temozolomide Resistance in Lower-grade Glioma.Cancer genomics & proteomicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimSystemic inflammation influences glioma progression. We evaluated the prognostic value of the white cell-to-lymphocyte ratio (WLR) and aiming to develop a practical survival prediction model. PATIENTS AND
methodsPatients with glioma from the INSCOC database were retrospectively analyzed and randomly split into training and validation cohorts (7:3). Kaplan-Meier analysis, restricted cubic splines, and Cox regression assessed associations between WLR and overall survival (OS). A WLR-based nomogram was established and internally validated using calibration and decision curve analysis.
resultsThe optimal WLR cutoff was 4.182. Patients with WLR ≥4.182 had significantly worse OS (
conclusionWLR is an independent, readily available prognostic marker in glioma. A WLR-based nomogram may aid individualized risk stratification and clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.